Skip to main content

Seeto Reginald's Form 4 filing

CareDx, Inc. (CDNA) · filed Aug 17, 2021

Accession no.
0001217234-21-000206
Filed
Aug 17, 2021
Trade date
Jun 25-Aug 11, 2021
Filing delay
53 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions and 5 derivative transactions. Open-market sales total $2.14M. It was filed 53 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Seeto ReginaldCIK 0001688485Director, Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 25, 2021Common StockMOption exerciseAcquired+3,247$24.35+$79,064.45135,618Direct
Jun 25, 2021Common StockMOption exerciseAcquired+5,963$27.72+$165,294.36141,581Direct
Jun 25, 2021Common StockSSaleDisposed−9,210$95.15F2−$876,331.5132,371Direct
Jun 28, 2021Common StockMOption exerciseAcquired+1,545$24.35+$37,620.75133,916Direct
Jun 28, 2021Common StockMOption exerciseAcquired+11,667$27.17+$316,992.39145,583Direct
Jun 28, 2021Common StockSSaleDisposed−8,522$95.42F3−$813,169.24137,061Direct
Jun 28, 2021Common StockSSaleDisposed−4,690$96.34F4−$451,834.6132,371Direct
Aug 11, 2021Common StockMOption exerciseAcquired+10,821$27.72+$299,958.12143,192Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 25, 2021Common StockMOption exerciseDisposed−3,247$0.00$031,961Direct
Jun 25, 2021Common StockMOption exerciseDisposed−5,963$0.00$066,869Direct
Jun 28, 2021Common StockMOption exerciseDisposed−1,545$0.00$030,416Direct
Jun 28, 2021Common StockMOption exerciseDisposed−11,667$0.00$014,500Direct
Aug 11, 2021Common StockMOption exerciseDisposed−10,821$0.00$056,048Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $90.37, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $96.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.10 to $96.53, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Remarks

President & Chief Executive Officer

Read the full filing on SEC EDGAR (opens in a new tab)